URANIUM ROYALTY CORP (UROY) Stock Overview
USA - NASDAQ:UROY - CA91702V1013 - Common Stock
UROY Key Statistics, Chart & Performance
The current stock price of UROY is 4.28 USD. In the past month the price increased by 30.89%. In the past year, price increased by 62.74%.
UROY Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CCJ | CAMECO CORP | 96.75 | 36.65B | ||
| LEU | CENTRUS ENERGY CORP-CLASS A | 63.73 | 6.25B | ||
| UEC | URANIUM ENERGY CORP | N/A | 6.14B | ||
| NXE | NEXGEN ENERGY LTD | N/A | 4.97B | ||
| CNR | CORE NATURAL RESOURCES INC | 26.2 | 4.57B | ||
| BTU | PEABODY ENERGY CORP | 25.4 | 3.89B | ||
| UUUU | ENERGY FUELS INC | N/A | 3.81B | ||
| ARLP | ALLIANCE RESOURCE PARTNERS | 13.21 | 3.27B | ||
| DNN | DENISON MINES CORP | N/A | 2.51B | ||
| NRP | NATURAL RESOURCE PARTNERS LP | 10.15 | 1.42B | ||
| URG | UR-ENERGY INC | N/A | 635.31M | ||
| LTBR | LIGHTBRIDGE CORP | N/A | 632.91M |
Related stock screener links
About UROY
Company Profile
Uranium Royalty Corp. operates as an exploration company, which engages in acquiring and assembling a portfolio of royalties, and investing in companies with exposure to uranium and physical uranium. The company is headquartered in Vancouver, British Columbia and currently employs 14 full-time employees. The company went IPO on 2019-12-06. The firm is focused on gaining exposure to uranium prices by making strategic investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, as well as through holdings of physical uranium. Its portfolio includes Anderson, Church Rock, Cigar Lake/Waterbury Lake, Dawn Lake, Dewey-Burdock, Energy Queen, Langer Heinrich, McArthur River, Michelin, Reno Creek, Millennium, Cree Extension and others. The Anderson Project is an advanced stage conventional uranium project, covering 8,268 acres, and is in Yavapai County, west-central Arizona, approximately 75 miles northwest of Phoenix and 43 miles northwest of Wickenburg. The Churchrock Project is an advanced stage, in-situ recovery uranium project located in the Grants Mineral Belt of New Mexico. The firm has a 2% gross overriding royalty on Aberdeen Project in Nunavut.
Company Info
URANIUM ROYALTY CORP
1830 - 1188 West Georgia Street, Suite 1830
Vancouver BRITISH COLUMBIA CA
CEO: Scott Melbye
Employees: 14
Phone: 16046301000
URANIUM ROYALTY CORP / UROY FAQ
What is the stock price of URANIUM ROYALTY CORP today?
The current stock price of UROY is 4.28 USD. The price increased by 1.9% in the last trading session.
What is the ticker symbol for URANIUM ROYALTY CORP stock?
The exchange symbol of URANIUM ROYALTY CORP is UROY and it is listed on the Nasdaq exchange.
On which exchange is UROY stock listed?
UROY stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for URANIUM ROYALTY CORP stock?
8 analysts have analysed UROY and the average price target is 3.84 USD. This implies a price decrease of -10.37% is expected in the next year compared to the current price of 4.28. Check the URANIUM ROYALTY CORP stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is URANIUM ROYALTY CORP worth?
URANIUM ROYALTY CORP (UROY) has a market capitalization of 571.98M USD. This makes UROY a Small Cap stock.
How many employees does URANIUM ROYALTY CORP have?
URANIUM ROYALTY CORP (UROY) currently has 14 employees.
What are the support and resistance levels for URANIUM ROYALTY CORP (UROY) stock?
URANIUM ROYALTY CORP (UROY) has a support level at 4.19. Check the full technical report for a detailed analysis of UROY support and resistance levels.
Is URANIUM ROYALTY CORP (UROY) expected to grow?
The Revenue of URANIUM ROYALTY CORP (UROY) is expected to grow by 174.39% in the next year. Check the estimates tab for more information on the UROY EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy URANIUM ROYALTY CORP (UROY) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of UROY, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of UROY, evaluating the profitability, health, valuation and growth aspects
- URANIUM ROYALTY CORP (UROY) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- URANIUM ROYALTY CORP (UROY) Sales and EPS estimates to see what analysts future expectations are.
- URANIUM ROYALTY CORP (UROY) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- URANIUM ROYALTY CORP (UROY) Insider and Institutional Ownership to learn about the owners and their transactions.
- URANIUM ROYALTY CORP (UROY) Stock Chart to make your own analysis
- URANIUM ROYALTY CORP (UROY) Latest news and press-releases to stay up to date.
Does URANIUM ROYALTY CORP (UROY) stock pay dividends?
UROY does not pay a dividend.
When does URANIUM ROYALTY CORP (UROY) report earnings?
URANIUM ROYALTY CORP (UROY) will report earnings on 2025-12-10.
What is the Price/Earnings (PE) ratio of URANIUM ROYALTY CORP (UROY)?
URANIUM ROYALTY CORP (UROY) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.01).
What is the Short Interest ratio of URANIUM ROYALTY CORP (UROY) stock?
The outstanding short interest for URANIUM ROYALTY CORP (UROY) is 8.89% of its float. Check the ownership tab for more information on the UROY short interest.
UROY Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to UROY. When comparing the yearly performance of all stocks, UROY is one of the better performing stocks in the market, outperforming 93.55% of all stocks.
UROY Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to UROY. No worries on liquidiy or solvency for UROY as it has an excellent financial health rating, but there are worries on the profitability.
UROY Financial Highlights
Over the last trailing twelve months UROY reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS decreased by -117% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.66% | ||
| ROE | -0.66% | ||
| Debt/Equity | 0 |
UROY Forecast & Estimates
8 analysts have analysed UROY and the average price target is 3.84 USD. This implies a price decrease of -10.37% is expected in the next year compared to the current price of 4.28.
For the next year, analysts expect an EPS growth of 700.6% and a revenue growth 174.39% for UROY